1. Home
  2. AKYA

as 05-17-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Industrials

Medical Specialities

Nasdaq

Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.

Founded: 2015 Country:
United States
United States
Employees: N/A City: MARLBOROUGH
Market Cap: 137.8M IPO Year: 2021
Target Price: $7.79 AVG Volume (30 days): 210.6K
Analyst Decision: Strong Buy Number of Analysts: 8
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.45 EPS Growth: N/A
52 Week Low/High: $2.65 - $8.80 Next Earning Date: 05-13-2024
Revenue: $93,573,000 Revenue Growth: 17.89%
Revenue Growth (this year): 22.19% Revenue Growth (next year): 18.42%

Share on Social Networks:

Stock Insider Trading Activity of Akoya BioSciences Inc. (AKYA)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
McKelligon Brian AKYA President and CEO Mar 13 '24 Sell $4.94 7,500 $37,042.50 231,868 SEC Form 4
McKelligon Brian AKYA President and CEO Mar 13 '24 Sell $4.94 7,500 $37,035.00 224,368 SEC Form 4
McKelligon Brian AKYA President and CEO Dec 19 '23 Sell $4.48 7,500 $33,565.50 152,563 SEC Form 4
McKelligon Brian AKYA President and CEO Dec 12 '23 Sell $4.25 7,500 $31,871.25 152,563 SEC Form 4